A 4-Year Follow-up, Blinded-Outcomes Trial of Subjects Having Received Stannsoporfin or Placebo in Clinical Trial 64,185-202
A 4-Year Follow-up, Blinded-Outcomes Trial of Subjects Having Received Stannsoporfin or Placebo in Clinical Trial 64,185-202
Observational follow-up of participants from earlier interventional trial 64,185-202 (NCT00850993).
No interventions were administered during this follow-up study.
Inclusion Criteria:
Participants who received treatment in clinical trial 64,185-202 and for whom informed consent was given for long term safety followup
Exclusion Criteria:
Participants were excluded by the investigator for medical reasons or by parents/guardians withdrawing consent